Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × ibrutinib × Clear all

NCT02548962 2019-11-21

Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma

Phase 1/2 Terminated

11 enrolled 12 charts

Multiple Myeloma